Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Debbie Rigby
Why Inhaler Device Design and Technique Matters
Dr Philip Tong
Facial Rashes Case Studies – Practical Guide to Assessment and Management
Dr Rupert Hinds
Abdominal Pain in Children – Practical Approach in GP
Prof Roger Chen
Practical Guide to Improving Control of T2D
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
